This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Endoscopic Retrograde Cholangiopancreatography (ERCP) industry.
How has the endoscopic retrograde cholangiopancreatography (ercp) market size changed in recent years, and what is the outlook ahead?
The endoscopic retrograde cholangiopancreatography (ERCP) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.87%. The growth in the historic period can be attributed to the rising prevalence of various chronic gastrointestinal diseases, rising application of ERCP, rising incidence of pancreatic cancer, rising investments by governments, and the rise in medical tourism.
The endoscopic retrograde cholangiopancreatography (ERCP) market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 8.58%. The growth in the forecast period can be attributed to the increasing prevalence of gastrointestinal conditions, rising incidence of cancer, growing focus on investments, increasing incidence of pancreatic duct, and rising demand for endoscopes. Major trends in the forecast period include technological advancements, partnerships for the R&D, expansion of the healthcare infrastructure, expansion of government healthcare, and development of advanced products.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp
What are the top economic and technological drivers pushing endoscopic retrograde cholangiopancreatography (ercp) market growth?
The increasing prevalence of gastrointestinal conditions is expected to propel the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market going forward. Gastrointestinal conditions refer to a broad range of disorders or diseases that affect the gastrointestinal (GI) tract, which includes the mouth, esophagus, stomach, small intestine, large intestine (colon), rectum, and anus, as well as accessory organs like the liver, gallbladder, and pancreas. The increasing prevalence of gastrointestinal conditions can be attributed to several factors, including dietary changes, an aging population, antibiotic use, lifestyle factors, and environmental influences. ERCP helps treat patients with gastrointestinal conditions by providing a minimally invasive method to diagnose and treat issues within the bile and pancreatic ducts, such as gallstones, strictures, tumors, or infections. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization, it is estimated that there are about 26,890 new cases of stomach cancer in the United States with around 10,880 deaths expected from this type of cancer. Therefore, the increasing prevalence of gastrointestinal conditions is driving the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market.
How is the endoscopic retrograde cholangiopancreatography (ercp) market segmented by product, application, and end-user?
The endoscopic retrograde cholangiopancreatography (ERCP) market covered in this report is segmented –
1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices
2) By Disease Indication: Gastroesophageal Reflux Disease (GERD), Gastrointestinal Cancer, Barrett’s Esophagus, Bile Duct Diseases, Peptic Ulcer Disease, Crohn’s Disease, Intestinal Pseudo-Obstruction, Ogilvie Syndrome, Other Indications
3) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin
4) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes
2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps
3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes
4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems
View The Full Market Report:
Which major trends are influencing the growth of the endoscopic retrograde cholangiopancreatography (ercp) industry?
Major companies operating in the ERCP market are focusing on developing innovative technologies, such as the cholangioscope direct visualisation system, to provide advanced, high-resolution direct visualisation of the bile and pancreatic ducts. The cholangioscope direct visualization system is a medical device that provides advanced, high-resolution imaging of the bile and pancreatic ducts during ERCP procedures. For instance, in July 2024, Penlon Limited, a UK-based medical device company, launched the VedVision Cholangioscope Direct Visualisation System, an advanced medical device designed for high-resolution, direct visualization of the bile and pancreatic ducts, enhancing diagnosis and therapeutic intervention during ERCP procedures. It features a 2 mm accessory channel and a dedicated guidewire channel for secure access, supported by a full range of accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.
Which leading companies are dominating the endoscopic retrograde cholangiopancreatography (ercp) market landscape?
Major companies operating in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.
Which geographic areas are expected to offer the highest growth opportunities in theendoscopic retrograde cholangiopancreatography (ercp) market?
North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20770
Need Customized Data On Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20770&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
